- recruiting
The role of the carotid chemoreflex in long-COVID
This study investigates why some people with Long COVID have ongoing breathing problems. We're looking at a small organ in the neck called the carotid body, which helps control breathing. We want to see if temporarily calming it down can improve breathing for those affected.
United Kingdom · England - active not recruitingNA
Balance Acceptance and Commitment Therapy for Long COVID
This study is testing a new talking therapy called Balance Acceptance and Commitment Therapy (Balance ACT) for people with Long COVID. It aims to see if this therapy can improve their quality of life compared to just receiving a self-help leaflet.
United Kingdom - recruitingPHASE2
Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
This study looks at a new treatment called PNMR for Long COVID. We want to see if PNMR, along with care and lifestyle advice, can help people feel better. It involves comparing PNMR with standard care over six weeks.
Canada - active not recruiting
A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay
This study looks at people with Long COVID, ME/CFS, and PTLDS to understand how their immune system, specifically T-cells, might be working differently. Researchers want to see if these differences can help explain their ongoing symptoms.
United Kingdom - recruitingNA
Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial
This study looks into whether a nerve block injection called Stellate Ganglion Block (SGB) can help adults with long COVID symptoms like tiredness and brain fog. Half get the SGB, half get a dummy injection, and we see if symptoms improve.
Canada - active not recruitingNA
Investigating the Effectiveness of Vimida
This study is looking into 'Vimida', a digital programme for people with ongoing tiredness (fatigue) after COVID-19. It aims to see if Vimida can help reduce fatigue compared to usual care. It includes adults aged 18 and over who have had fatigue for at least three months.
Germany - completed
Understanding the role of community pharmacy in the support of people with long COVID
This study looks at how local chemists (community pharmacies) can better support people in the UK living with "long COVID." Researchers will talk to people with long COVID and pharmacy staff to create a useful online training course for pharmacists to help them understand and assist those with ongoing symptoms.
United Kingdom · England · Northern Ireland